Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Immunotherapy of type 1 diabetes: where are we and where should we be going?

Luo X, Herold KC, Miller SD.

Immunity. 2010 Apr 23;32(4):488-99. doi: 10.1016/j.immuni.2010.04.002. Review.

2.
3.

Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.

Piccirillo CA, Tritt M, Sgouroudis E, Albanese A, Pyzik M, Hay V.

Ann N Y Acad Sci. 2005 Jun;1051:72-87. Review.

PMID:
16126946
4.

Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.

Nikolic T, Welzen-Coppens JM, Leenen PJ, Drexhage HA, Versnel MA.

Immunobiology. 2009;214(9-10):791-9. doi: 10.1016/j.imbio.2009.06.002. Epub 2009 Jul 22. Review.

PMID:
19628297
5.

Immunotherapy for the prevention and treatment of type 1 diabetes.

Goudy KS, Tisch R.

Int Rev Immunol. 2005 Sep-Dec;24(5-6):307-26. Review.

PMID:
16318984
6.

Immune intervention in type 1 diabetes.

Michels AW, Eisenbarth GS.

Semin Immunol. 2011 Jun;23(3):214-9. doi: 10.1016/j.smim.2011.07.003. Epub 2011 Aug 17. Review.

7.

The potential role of dendritic cells in the therapy of Type 1 diabetes.

Lee CN, Lew AM, Wu L.

Immunotherapy. 2013 Jun;5(6):591-606. doi: 10.2217/imt.13.48. Review.

PMID:
23725283
8.

How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.

Vives-Pi M, Rodríguez-Fernández S, Pujol-Autonell I.

Apoptosis. 2015 Mar;20(3):263-72. doi: 10.1007/s10495-015-1090-8. Review.

9.

Immunotherapy in autoimmune type 1 diabetes.

Weigmann B, Franke RK, Daniel C.

Rev Diabet Stud. 2012 Summer-Fall;9(2-3):68-81. doi: 10.1900/RDS.2012.9.68. Epub 2012 Nov 15. Review.

10.

Mechanistic basis of immunotherapies for type 1 diabetes mellitus.

Chen W, Xie A, Chan L.

Transl Res. 2013 Apr;161(4):217-29. doi: 10.1016/j.trsl.2012.12.017. Epub 2013 Jan 22. Review.

11.

T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives.

Boitard C.

Diabetes Metab. 2013 Dec;39(6):459-66. doi: 10.1016/j.diabet.2013.08.001. Epub 2013 Oct 18. Review.

PMID:
24139825
12.

Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes.

Prasad S, Xu D, Miller SD.

Rev Diabet Stud. 2012 Winter;9(4):319-27. doi: 10.1900/RDS.2012.9.319. Epub 2012 Dec 28. Review.

13.

2011 Update: antigen-specific therapy in type 1 diabetes.

Michels AW, von Herrath M.

Curr Opin Endocrinol Diabetes Obes. 2011 Aug;18(4):235-40. doi: 10.1097/MED.0b013e32834803ae. Review.

14.

Peptide immunotherapies in Type 1 diabetes: lessons from animal models.

Fierabracci A.

Curr Med Chem. 2011;18(4):577-86. Review.

PMID:
21143110
15.

CD8+ T cells in type 1 diabetes.

Tsai S, Shameli A, Santamaria P.

Adv Immunol. 2008;100:79-124. doi: 10.1016/S0065-2776(08)00804-3. Review.

PMID:
19111164
16.

Immune intervention for type 1 diabetes mellitus.

Skyler JS.

Int J Clin Pract Suppl. 2011 Feb;(170):61-70. doi: 10.1111/j.1742-1241.2010.02580.x. Review.

PMID:
21323814
17.

B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes.

Silveira PA, Grey ST.

Trends Endocrinol Metab. 2006 May-Jun;17(4):128-35. Epub 2006 Apr 3. Review.

PMID:
16580840
18.

Invasion of the killer B's in type 1 diabetes.

Silveira PA, Serreze DV, Grey ST.

Front Biosci. 2007 Jan 1;12:2183-93. Review.

PMID:
17127455
19.

Antigen-specific therapy against type 1 diabetes: mechanisms and perspectives.

Wan X, Zaghouani H.

Immunotherapy. 2014;6(2):155-64. doi: 10.2217/imt.13.172. Review.

PMID:
24491089
20.

Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?

Li DS, Warnock GL, Tu HJ, Ao Z, He Z, Lu H, Dai LJ.

Life Sci. 2009 Oct 7;85(15-16):549-56. doi: 10.1016/j.lfs.2009.08.016. Epub 2009 Sep 9. Review.

PMID:
19747492

Supplemental Content

Support Center